217 related articles for article (PubMed ID: 23410974)
1. Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia.
Khandanpour C; Phelan JD; Vassen L; Schütte J; Chen R; Horman SR; Gaudreau MC; Krongold J; Zhu J; Paul WE; Dührsen U; Göttgens B; Grimes HL; Möröy T
Cancer Cell; 2013 Feb; 23(2):200-14. PubMed ID: 23410974
[TBL] [Abstract][Full Text] [Related]
2. Growth factor independence 1 (Gfi1) as a regulator of p53 activity and a new therapeutical target for ALL.
Khandanpour C; Möröy T
Oncotarget; 2013 Mar; 4(3):374-5. PubMed ID: 23528269
[TBL] [Abstract][Full Text] [Related]
3. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
[TBL] [Abstract][Full Text] [Related]
4. BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death.
Akhtar RS; Geng Y; Klocke BJ; Latham CB; Villunger A; Michalak EM; Strasser A; Carroll SL; Roth KA
J Neurosci; 2006 Jul; 26(27):7257-64. PubMed ID: 16822983
[TBL] [Abstract][Full Text] [Related]
5. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.
Villunger A; Michalak EM; Coultas L; Müllauer F; Böck G; Ausserlechner MJ; Adams JM; Strasser A
Science; 2003 Nov; 302(5647):1036-8. PubMed ID: 14500851
[TBL] [Abstract][Full Text] [Related]
6. Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate.
Hudson CD; Morris PJ; Latchman DS; Budhram-Mahadeo VS
J Biol Chem; 2005 Mar; 280(12):11851-8. PubMed ID: 15598651
[TBL] [Abstract][Full Text] [Related]
7. Sall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicin.
Escobar D; Hepp MI; Farkas C; Campos T; Sodir NM; Morales M; Álvarez CI; Swigart L; Evan GI; Gutiérrez JL; Nishinakamura R; Castro AF; Pincheira R
Cell Death Dis; 2015 Jul; 6(7):e1816. PubMed ID: 26181197
[TBL] [Abstract][Full Text] [Related]
8. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
[TBL] [Abstract][Full Text] [Related]
9. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
10. Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.
Happo L; Cragg MS; Phipson B; Haga JM; Jansen ES; Herold MJ; Dewson G; Michalak EM; Vandenberg CJ; Smyth GK; Strasser A; Cory S; Scott CL
Blood; 2010 Dec; 116(24):5256-67. PubMed ID: 20829369
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.
Barnes BJ; Kellum MJ; Pinder KE; Frisancho JA; Pitha PM
Cancer Res; 2003 Oct; 63(19):6424-31. PubMed ID: 14559832
[TBL] [Abstract][Full Text] [Related]
12. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
[TBL] [Abstract][Full Text] [Related]
13.
Hof J; Kox C; Groeneveld-Krentz S; Bandapalli OR; Karawajew L; Schedel K; Kunz JB; Eckert C; Ludwig WD; Ratei R; Rhein P; Henze G; Muckenthaler MU; Kulozik AE; von Stackelberg A; Kirschner-Schwabe R
Haematologica; 2017 Jul; 102(7):e249-e252. PubMed ID: 28360149
[No Abstract] [Full Text] [Related]
14. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
[TBL] [Abstract][Full Text] [Related]
15. Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.
Kim JH; Penson AV; Taylor BS; Petrini JHJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15178-15183. PubMed ID: 31285322
[TBL] [Abstract][Full Text] [Related]
16. Growth factor independence 1 protects hematopoietic stem cells against apoptosis but also prevents the development of a myeloproliferative-like disease.
Khandanpour C; Kosan C; Gaudreau MC; Dührsen U; Hébert J; Zeng H; Möröy T
Stem Cells; 2011 Feb; 29(2):376-85. PubMed ID: 21732494
[TBL] [Abstract][Full Text] [Related]
17. Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant.
Slatter TL; Hung N; Bowie S; Campbell H; Rubio C; Speidel D; Wilson M; Baird M; Royds JA; Braithwaite AW
Cell Death Dis; 2015 Jun; 6(6):e1783. PubMed ID: 26068791
[TBL] [Abstract][Full Text] [Related]
18. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
19. Growth factor independent-1 maintains Notch1-dependent transcriptional programming of lymphoid precursors.
Phelan JD; Saba I; Zeng H; Kosan C; Messer MS; Olsson HA; Fraszczak J; Hildeman DA; Aronow BJ; Möröy T; Grimes HL
PLoS Genet; 2013; 9(9):e1003713. PubMed ID: 24068942
[TBL] [Abstract][Full Text] [Related]
20. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.
Lin S; Tian L; Shen H; Gu Y; Li JL; Chen Z; Sun X; You MJ; Wu L
Oncogene; 2013 Oct; 32(40):4845-53. PubMed ID: 23108395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
